Monthly E-Newsletter - September 2023

Pharma Advancement Newsletter

Advertise With Us

September - 2023 - Volume 9 I Pharma Advancement E-Newsletter

Industry Updates

Deciphering The Impact of EU HTA On Emerging Biopharma

Emerging biopharmaceutical companies have to navigate increased evidence demands as well as uncertainties in the upcoming EU HTA for accelerated market access.

Antibiotic Waste Management In Pharmaceutical Manufacturing

Enhancing Medication Security Through Pharma Traceability

Drug Supply Chain Security Act Enforcement Delayed To 2024

The Impact of DSCSA EDDS Guidance On Pharmaceutical Industry

The DSCSA EDDS guidance by the FDA underscores ongoing progress in pharmaceutical traceability & compliance, emphasizing data exchange and operational aspects.

CDMO Insights

Rising Demand For CDMO's Amid COVID-19 Reshaping API Market

The COVID-19 pandemic drove demand for CDMO services and reshaped the API market; the Asia-Pacific region emerged, with India and China as the main players.

AAV Gene Therapy CDMO's Shaping The Future With A $2.57B Goal

AAV-focused cell & gene therapy CDMO market is set for growth; challenges in scalability, competition, tie-ups, and more accelerates AAV therapy availability.

CDMO Strategies Are Key To Success In The Biopharma Sector

Customer-centricity alongside cohesive teams matters when choosing a CDMO in biopharma; success through teamwork as well as expertise is definitely achievable.

Popular Events

World Cancer Series: Europe
2022-09-20 - 2022-09-21
Marriott Hotel Grand Place, Brussels

DigIT Pharma Conference 2023
2023-09-25 - 2023-09-27
tbc.,Berlin, Germany

Achema 2024 & Health 2023
2022-09-25 - 2022-09-27
tbc.,Berlin, Germany

WORLD DRUG SAFETY CONGRESS AMERICAS
2024-06-10 - 2024-06-14
Exhibition grounds of Messe Frankfurt GmbH, Ludwig-Erhard-Anlage 1, 60327 Frankfurt am Main, Germany

ACHEMA 2024
2023-10-18 - 2023-10-19
Sheraton Boston Hotel – 39 Dalton Street, Boston, Massachusetts 02199

Advertise Your Content

Advertise in Our Next Issue - Contact

Peter Menon
P: +91 6304637675
E: peter@pharmaadvancement.com

Editorial Inquiries

Advertising Inquiries